dexmethylphenidate hydrochloride has been researched along with s 1743 in 1 studies
| Studies (dexmethylphenidate hydrochloride) | Trials (dexmethylphenidate hydrochloride) | Recent Studies (post-2010) (dexmethylphenidate hydrochloride) | Studies (s 1743) | Trials (s 1743) | Recent Studies (post-2010) (s 1743) |
|---|---|---|---|---|---|
| 65 | 27 | 22 | 1,228 | 569 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, P; Gellad, WF; Good, CB; Kesselheim, AS; Mizah, M | 1 |
1 other study(ies) available for dexmethylphenidate hydrochloride and s 1743
| Article | Year |
|---|---|
Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011.
Topics: Antidotes; Azabicyclo Compounds; Benzhydryl Compounds; Bronchodilator Agents; Central Nervous System Stimulants; Cetirizine; Dexlansoprazole; Dexmethylphenidate Hydrochloride; Drug Approval; Drug Prescriptions; Drugs, Generic; Esomeprazole; Eszopiclone; Ethanolamines; Formoterol Fumarate; Histamine H1 Antagonists, Non-Sedating; Humans; Hypnotics and Sedatives; Levoleucovorin; Medicaid; Modafinil; Patents as Topic; Piperazines; Proton Pump Inhibitors; Retrospective Studies; Stereoisomerism; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents | 2014 |